Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of MyMD Pharmaceuticals patents

List of MyMD Pharmaceuticals patents

List of Spatial Photonics patents

List of 7-Eleven patents

List of Invensense, Inc. patents

List of Axeleo Capital portfolio companies

Investors in Sportsicon

Patents where

Current Assignee

Name

is

MyMD Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10918633 Method of treating coronavirus	Patent 10918633 was granted and assigned to MyMD Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10918633	February 16, 2021
	‌ US Patent 9884055 Method of treating substance addictions	Patent 9884055 was granted and assigned to MyMD Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	9884055	February 6, 2018
	‌ US Patent 10517856 Methods of altering programmed cell death and extending cell life	Patent 10517856 was granted and assigned to MyMD Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10517856	December 31, 2019
	‌ US Patent 10471052 Method of treating addictions to opioids	Patent 10471052 was granted and assigned to MyMD Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10471052	November 12, 2019
	‌ US Patent 10588899 Methods of treating diabetes	Patent 10588899 was granted and assigned to MyMD Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10588899	March 17, 2020
	‌ US Patent 10786493 Method of treating viral infections	Patent 10786493 was granted and assigned to MyMD Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10786493	September 29, 2020
	‌ US Patent 10806728 Pharmaceutical salts of isomyosmine and pharmaceutical compositions containing same	Patent 10806728 was granted and assigned to MyMD Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10806728	October 20, 2020
	‌ US Patent 10835523 Method of regulating tumor necrosis factor-alpha (TNF-α) for treating cancers, autoimmune disorders, and other disorders associated with chronic inflammation	Patent 10835523 was granted and assigned to MyMD Pharmaceuticals on November, 2020 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10835523	November 17, 2020
	‌ US Patent 11629355 Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction and Alzheimer's disease	Patent 11629355 was granted and assigned to MyMD Pharmaceuticals on April, 2023 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	11629355	April 18, 2023
	‌ US Patent 10722506 Method of treating multiple sclerosis	Patent 10722506 was granted and assigned to MyMD Pharmaceuticals on July, 2020 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10722506	July 28, 2020
	‌ US Patent 10213438 Alkaloid compounds for treating depression, substance addictions, and indications associated with chronic inflammation	Patent 10213438 was granted and assigned to MyMD Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	10213438	February 26, 2019
	‌ US Patent 11938126 Method of treating diseases of the visual system	Patent 11938126 was granted and assigned to MyMD Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.	MyMD Pharmaceuticals	MyMD Pharmaceuticals		United States Patent and Trademark Office	11938126	March 26, 2024

12 results

0 selected

12 results

0 selected